Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| AJU IB Investment | ajuib.co.kr |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 18, 2025 | Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening Biomarker-Driven Pathway | Meaningful improvements confirmed in slow-progressor subgroup; biomarker reductions support precision-medicine approach and potential FDA accelerated pathway SEOUL, South Korea, Sept. 18, 2025 /PRNewswire/ -- CorestemChemon Inc. (KOSDAQ: 16... |
| Aug 7, 2024 | I AM ALS Announces the Cures Collective to Accelerate Neurodegenerative Disease Collaboration, Awareness, & Progress | WASHINGTON, Aug. 7, 2024 /PRNewswire/ -- I AM ALS announced today the launch of the Cures Collective, a neurodegenerative condition coalition. This group of advocates and partner organizations will focus on filling gaps, strengthening colle... |
Reviews 0
FAQ about (주)코아스템
Who has invested in (주)코아스템?
Parsers VC lists 2 investors of (주)코아스템, among them AJU IB Investment.
What has the press written about (주)코아스템?
Parsers VC has collected 3 articles mentioning (주)코아스템, among them “Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening Biomarker-Driven Pathway” (Sep 18, 2025) and “I AM ALS Announces the Cures Collective to Accelerate Neurodegenerative Disease Collaboration, Awareness, & Progress” (Aug 7, 2024).
Is (주)코아스템 still active?
Yes, (주)코아스템 is active; its latest activity on Parsers VC dates from Jul 20, 2026.